Authors: BERGHOLM U BERGSTROM R EKBOM A

Citation: U. Bergholm et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID (VOL 79, PG 132, 1997), Head & neck, 20(4), 1998, pp. 361-361

Authors: ALEMI M LUCAS SD SALLSTROM JF BERGHOLM U AKERSTROM G WILANDER E

Citation: M. Alemi et al., A COMPLEX 9 BASE-PAIR DELETION IN RET EXON-11 COMMON IN SPORADIC MEDULLARY-THYROID CARCINOMA, Oncogene, 14(17), 1997, pp. 2041-2045

Authors: BERGHOLM U BERGSTROM R EKBOM A

Citation: U. Bergholm et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID, Cancer, 79(1), 1997, pp. 132-138

Authors: WANG WL JOHANSSON H BERGHOLM U WILANDER E GRIMELIUS L

Citation: Wl. Wang et al., APOPTOSIS AND EXPRESSION OF THE PROTOONCOGENES BCL-2 AND P53 AND THE PROLIFERATION FACTOR KI-67 IN HUMAN MEDULLARY-THYROID CARCINOMA, Endocrine pathology, 7(1), 1996, pp. 37-45

Authors: VIALE G RONCALLI M GRIMELIUS L GRAZIANI D WILANDER E JOHANSSON H BERGHOLM U COGGI G

Citation: G. Viale et al., PROGNOSTIC VALUE OF BCL-2 IMMUNOREACTIVITY IN MEDULLARY-THYROID CARCINOMA, Human pathology, 26(9), 1995, pp. 945-950

Authors: ZEDENIUS J LARSSON C BERGHOLM U BOVEE J SVENSSON A HALLENGREN B GRIMELIUS L BACKDAHL M WEBER G WALLIN G

Citation: J. Zedenius et al., MUTATIONS OF CODON-918 IN THE RET PROTOONCOGENE CORRELATE TO POOR-PROGNOSIS IN SPORADIC MEDULLARY-THYROID CARCINOMAS, The Journal of clinical endocrinology and metabolism, 80(10), 1995, pp. 3088-3090